Loading...
This week, NEJM Journal Watch, Physician's First Watch, and CardioExchange, an online forum for cardiology news and discussion, have brought you coverage of study findings presented at the American Heart Association's 2014 Scientific Sessions in Chicago. Here is a compilation of that coverage. (Your registration at CardioExchange and your NEJM Journal Watch subscription are required, except where noted.)
Risk and Benefit of Prolonged Dual Antiplatelet Therapy After Drug-eluting Coronary Stents: Primary Endpoint Results from the Dual Antiplatelet Therapy Study (Mauri L et al.)
NEJM Journal Watch (free)
Is 6 Months DAPT Post Coronary Stenting Non Inferior To 24 Months? The Italic/Italic+ Randomized Trial. Results of the One Ye…